QT Medical, Inc. (QT Medical), a medtech company focusing on electrocardiogram (ECG or EKG) technology, announces today that it raised $12 million in Series B financing. This funding will accelerate QT Medical’s market penetration, global expansion, product pipeline development, and long-term strategic planning.

We extend our heartfelt gratitude for your continuous support. QT Medical is pleased to inform you that our Taipei office has relocated to a new address: 6th Floor, No. 9, Section 1, Zhongxiao East Road, Zhongzheng District, Taipei City 10009, Taiwan

QT Medical Wins Taipei Biotech Award 2021 !

How to Choose the Best ECG Machine for Your Clinical Practice

QT MEDICAL_Medical Taiwan_Medical devices & equipment

Cardiovascular disease is the second among the top ten causes of death in China. Time is the most important key to treating patients with acute myocardial infarction. In order to assist Taichung to improve emergency rescue energy, the Taiwan Branch of American Merchant Uxin Biomedical Co., Ltd. specially donated 15 sets of 12-lead ECG systems.

QT Medical launches the worlds first 12-lead ECG service for home use - Xpress ECG™

QT Medical announces FDA clearance of PCA 500, a resting 12-lead electrocardiogram (ECG or EKG), for use in pediatric patients. First cleared in 2018 for professional and personal use by adults 18 years and older, PCA 500's new FDA clearance expands its indication for use to all pediatric populations, including: newborns, infants, children and adolescents.